NIK cleavage results in an increased stability of its C-terminal fragment and in the activation of noncanonical NF-κB signaling, whereas LIMA1 processing converts the tumor suppressor into an oncogene [70,71]. The gene discussed is NFKB1; the disease is neoplasm.